Recombinant multi-species HBG2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine HBG2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The gamma globin genes (HBG1 and HBG2) are normally expressed in the fetal liver, spleen and bone marrow. Two gamma chains together with two alpha chains constitute fetal hemoglobin (HbF) which is normally replaced by adult hemoglobin (HbA) at birth. In some beta-thalassemias and related conditions, gamma chain production continues into adulthood. The two types of gamma chains differ at residue 136 where glycine is found in the G-gamma product (HBG2) and alanine is found in the A-gamma product (HBG1). The former is predominant at birth. The order of the genes in the beta-globin cluster is: 5'- epsilon -- gamma-G -- gamma-A -- delta -- beta--3'. [provided by RefSeq, Jul 2008]
The Alternative Names of target: Gamma-2-globin,HBG-T1,HBG2,Hb F Ggamma,Hemoglobin gamma-2 chain,Hemoglobin gamma-G chain,Hemoglobin subunit gamma-2,TNCY
Go
to HBG2 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP2887-Ag-1/ GM-Tg-hg-IP2887-Ag-2 | Human HBG2 protein | Human |
| GM-Tg-rg-IP2887-Ag-1/ GM-Tg-rg-IP2887-Ag-2 | Rat HBG2 protein | Rat |
| GM-Tg-mg-IP2887-Ag-1/ GM-Tg-mg-IP2887-Ag-2 | Mouse HBG2 protein | Mouse |
| GM-Tg-cynog-IP2887-Ag-1/ GM-Tg-cynog-IP2887-Ag-2 | Cynomolgus/Rhesus macaque HBG2 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP2887-Ag-1/ GM-Tg-felg-IP2887-Ag-2 | Feline HBG2 protein | Feline |
| GM-Tg-cang-IP2887-Ag-1/ GM-Tg-cang-IP2887-Ag-2 | Canine HBG2 protein | Canine |
| GM-Tg-bovg-IP2887-Ag-1/ GM-Tg-bovg-IP2887-Ag-2 | Bovine HBG2 protein | Bovine |
| GM-Tg-equg-IP2887-Ag-1/ GM-Tg-equg-IP2887-Ag-2 | Equine HBG2 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP2887-Ag-1/ GM-Tg-hg-IP2887-Ag-2;
GM-Tg-rg-IP2887-Ag-1/ GM-Tg-rg-IP2887-Ag-2;
GM-Tg-mg-IP2887-Ag-1/ GM-Tg-mg-IP2887-Ag-2; GM-Tg-cynog-IP2887-Ag-1/ GM-Tg-cynog-IP2887-Ag-2; GM-Tg-felg-IP2887-Ag-1/ GM-Tg-felg-IP2887-Ag-2; GM-Tg-cang-IP2887-Ag-1/ GM-Tg-cang-IP2887-Ag-2; GM-Tg-bovg-IP2887-Ag-1/ GM-Tg-bovg-IP2887-Ag-2; GM-Tg-equg-IP2887-Ag-1/ GM-Tg-equg-IP2887-Ag-2 |
| Products Name | HBG2 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | HBG2 |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine HBG2 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.